Literature DB >> 24067984

Kaposi's sarcoma-associated herpesvirus transactivator Rta induces cell cycle arrest in G0/G1 phase by stabilizing and promoting nuclear localization of p27kip.

Pankaj Kumar1, Charles Wood.   

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) immediate-early gene, replication, and transcription activator (K-Rta) is a key viral protein that serves as the master regulator for viral lytic replication. In this study, we investigated the role of K-Rta in cell cycle regulation and found that the expression of K-Rta in doxycycline (Dox)-inducible BJAB cells induced cell cycle arrest in G0/G1 phase. Western blot analysis of key cell cycle regulators revealed that K-Rta-mediated cell cycle arrest was associated with a decrease in cyclin A and phosphorylated Rb (pS807/pS811) protein levels, both markers of S phase progression, and an increase in protein levels for p27, a cyclin-dependent kinase inhibitor. Further, we found that K-Rta does not affect the transcription of p27 but regulates p27 at the posttranslational level by inhibiting its proteosomal degradation. Immunofluorescence staining and cell fractionation experiments revealed largely nuclear compartmentalization of p27 in K-Rta-expressing cells, demonstrating that K-Rta not only stabilizes p27 but also modulates its cellular localization. Finally, short hairpin RNA knockdown of p27 significantly abrogates cell cycle arrest in K-Rta-expressing cells, supporting its key role in K-Rta-mediated cell cycle arrest. Our findings are consistent with previous studies which showed that expression of immediate-early genes of several herpesviruses, including herpes simplex virus, Epstein-Barr virus, and cytomegalovirus, results in cell cycle arrest at the G0/G1 phase, possibly to avoid competition for resources needed for host cell replication during the S phase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067984      PMCID: PMC3838229          DOI: 10.1128/JVI.02540-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Skp2-mediated degradation of p27 regulates progression into mitosis.

Authors:  Keiko Nakayama; Hiroyasu Nagahama; Yohji A Minamishima; Satoshi Miyake; Noriko Ishida; Shigetsugu Hatakeyama; Masatoshi Kitagawa; Shun-ichiro Iemura; Tohru Natsume; Keiichi I Nakayama
Journal:  Dev Cell       Date:  2004-05       Impact factor: 12.270

2.  Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements.

Authors:  Pey-Jium Chang; Duane Shedd; Lyn Gradoville; Myung-Sam Cho; Lee-Wen Chen; Jimmy Chang; George Miller
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression.

Authors:  Hongyu Deng; Julia T Chu; Matthew B Rettig; Otoniel Martinez-Maza; Ren Sun
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

4.  Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest.

Authors:  Yoshihiro Izumiya; Su-Fang Lin; Thomas J Ellison; Alon M Levy; Greg L Mayeur; Chie Izumiya; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis.

Authors:  Rong Shao; Xing Guo
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).

Authors:  Frederick Y Wu; Shizhen Emily Wang; Qi-Qun Tang; Masahiro Fujimuro; Chuang-Jiun Chiou; Qizhi Zheng; Honglin Chen; S Diane Hayward; M Daniel Lane; Gary S Hayward
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression.

Authors:  Pankaj Trivedi; Kumi Takazawa; Claudia Zompetta; Laura Cuomo; Elena Anastasiadou; Antonino Carbone; Stefania Uccini; Filippo Belardelli; Kenzo Takada; Luigi Frati; Alberto Faggioni
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

9.  Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.

Authors:  Hiroyuki Nakamura; Michael Lu; Yousang Gwack; John Souvlis; Steven L Zeichner; Jae U Jung
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target.

Authors:  W K Nishioka; R M Welsh
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  8 in total

1.  Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Authors:  Bernadett Papp; Naeem Motlagh; Richard J Smindak; Seung Jin Jang; Aria Sharma; Juan D Alonso; Zsolt Toth
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

Review 2.  Modulation of DNA damage and repair pathways by human tumour viruses.

Authors:  Robert Hollingworth; Roger J Grand
Journal:  Viruses       Date:  2015-05-22       Impact factor: 5.048

3.  Productive herpesvirus lytic replication in primary effusion lymphoma cells requires S-phase entry.

Authors:  Robert Hollingworth; Grant S Stewart; Roger J Grand
Journal:  J Gen Virol       Date:  2020-08       Impact factor: 3.891

4.  Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.

Authors:  Robert Hollingworth; George L Skalka; Grant S Stewart; Andrew D Hislop; David J Blackbourn; Roger J Grand
Journal:  Viruses       Date:  2015-06-05       Impact factor: 5.048

5.  ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.

Authors:  Jennifer J Wood; James R Boyne; Christina Paulus; Brian R Jackson; Michael M Nevels; Adrian Whitehouse; David J Hughes
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.

Authors:  Dacai Xu; Jianglin Wang; Zhenkang Zhou; Zhiwei He; Qing Zhao
Journal:  Mol Med Rep       Date:  2015-10-23       Impact factor: 2.952

7.  Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Authors:  Laura Gonzalez Dos Anjos; Bruna Cristine de Almeida; Thais Gomes de Almeida; André Mourão Lavorato Rocha; Giovana De Nardo Maffazioli; Fernando Augusto Soares; Isabela Werneck da Cunha; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

8.  LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.

Authors:  Weidan Ji; Zhangxiao Peng; Bin Sun; Lei Chen; Qin Zhang; Minggao Guo; Changqing Su
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.